TY - JOUR
T1 - Ligand binding and structural changes associated with allostery in yeast NAD +-specific isocitrate dehydrogenase
AU - McAlister-Henn, Lee
N1 - Funding Information:
This work was supported by NIH Grant GM051265 . Previous contributors to this work include Daniel A. Keys, Jill R. Cupp-Vickery, Robert J. Haselbeck, Wen-Ning Zhao, Ellen A. Panisko, Mark T. McCammon, Gang Hu, and Joshua A. Garcia. Current contributors include An-Ping Lin, Karyl I. Minard, and Sondra L. Anderson. Collaborators at the UTHSCSA include P. John Hart, Alex B. Taylor, Susan T. Weintraub, Kevin W. Hakala, Borries Demeler, and Virgil Schirf.
PY - 2012/3/15
Y1 - 2012/3/15
N2 - Yeast NAD +-specific isocitrate dehydrogenase (IDH) is an octameric enzyme composed of four each of regulatory IDH1 and catalytic IDH2 subunits that share 42% sequence identity. IDH2 contains catalytic isocitrate/Mg 2+ and NAD + binding sites whereas IDH1 contains homologous binding sites, respectively, for cooperative binding of isocitrate and for allosteric binding of AMP. Ligand binding is highly ordered in vitro, and IDH exhibits the unusual property of half-site binding for all ligands. The structures of IDH solved in the absence or presence of ligands have shown: (a) a heterodimer to be the basic structural/functional unit of the enzyme, (b) the organization of heterodimers to form tetramer and octamer structures, (c) structural differences that may underlie cooperative and allosteric regulatory mechanisms, and (d) the possibility for formation of a disulfide bond that could reduce catalytic activity. In vivo analyses of mutant enzymes have elucidated the physiological importance of catalytic activity and allosteric regulation of this tricarboxylic acid cycle enzyme. Other studies have established the importance of a disulfide bond in regulation of IDH activity in vivo, as well as contributions of this bond to the property of half-site ligand binding exhibited by the wild-type enzyme.
AB - Yeast NAD +-specific isocitrate dehydrogenase (IDH) is an octameric enzyme composed of four each of regulatory IDH1 and catalytic IDH2 subunits that share 42% sequence identity. IDH2 contains catalytic isocitrate/Mg 2+ and NAD + binding sites whereas IDH1 contains homologous binding sites, respectively, for cooperative binding of isocitrate and for allosteric binding of AMP. Ligand binding is highly ordered in vitro, and IDH exhibits the unusual property of half-site binding for all ligands. The structures of IDH solved in the absence or presence of ligands have shown: (a) a heterodimer to be the basic structural/functional unit of the enzyme, (b) the organization of heterodimers to form tetramer and octamer structures, (c) structural differences that may underlie cooperative and allosteric regulatory mechanisms, and (d) the possibility for formation of a disulfide bond that could reduce catalytic activity. In vivo analyses of mutant enzymes have elucidated the physiological importance of catalytic activity and allosteric regulation of this tricarboxylic acid cycle enzyme. Other studies have established the importance of a disulfide bond in regulation of IDH activity in vivo, as well as contributions of this bond to the property of half-site ligand binding exhibited by the wild-type enzyme.
KW - Allosteric regulation
KW - Disulfide bond
KW - Half-site ligand binding
KW - Isocitrate dehydrogenase
KW - Tricarboxylic acid cycle
UR - http://www.scopus.com/inward/record.url?scp=84857818828&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857818828&partnerID=8YFLogxK
U2 - 10.1016/j.abb.2011.10.003
DO - 10.1016/j.abb.2011.10.003
M3 - Review article
C2 - 22008468
AN - SCOPUS:84857818828
SN - 0003-9861
VL - 519
SP - 112
EP - 117
JO - Archives of Biochemistry and Biophysics
JF - Archives of Biochemistry and Biophysics
IS - 2
ER -